Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.55 is 12% below its 5-year average of 2.88, near the low end of its 5-year range (1.88–7.25).
As of the fiscal period ended Tuesday, June 30, 2026. 18.85% above its 12-month average of 2.15.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.55.
CURRENT RATIO
2.55
CURRENT RATIO AVG TTM
2.15
CURRENT RATIO AVG 3Y
2.61
CURRENT RATIO AVG 5Y
2.88
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+18.85%
CURRENT VS 3Y AVG
-2.25%
CURRENT VS 5Y AVG
-11.56%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 506 covered companies
CURRENT VS SECTOR MEDIAN
-23.98%
vs the sector median at left
Market Cap
$1.52B
Current Ratio
1.52
TTM Avg
1.81
3Y Avg
2.10
5Y Avg
3.34
Market Cap
$1.65B
Current Ratio
2.91
TTM Avg
2.71
3Y Avg
3.12
5Y Avg
3.05
Market Cap
$1.66B
Current Ratio
4.69
TTM Avg
5.56
3Y Avg
3.02
5Y Avg
3.21
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Certara, Inc. (CERT) | $1.57B | 2.55 | 2.15 | 2.61 | 2.88 |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | 1.52 | 1.81 | 2.10 | 3.34 |
| Innoviva, Inc. (INVA)vs › | $1.52B | 16.01 | 8.50 | 7.33 | 23.22 |
| GH Research PLC (GHRS)vs › | $1.52B | 28.70 | 25.68 | 28.23 | 39.79 |
| Braveheart Bio, Inc. (BRVE)vs › | $1.51B | N/A | N/A | N/A | N/A |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | 1.89 | 2.40 | 2.37 | 2.65 |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 2.91 | 2.71 | 3.12 | 3.05 |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.66B | 4.69 | 5.56 | 3.02 | 3.21 |
| AnaptysBio, Inc. (ANAB)vs › | $1.46B | 5.61 | 9.29 | 11.65 | 16.84 |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.45B | 3.02 | 3.13 | 2.94 | 3.03 |
Current Ratio
2.55
Quick Ratio
2.55
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.55 |
| 2026-03-31 | 1.88 |
| 2025-12-31 | 2.05 |
| 2025-09-30 | 2.09 |
| 2025-06-30 | 2.16 |
| 2025-03-31 | 2.78 |
| 2024-12-31 | 2.13 |
| 2024-09-30 | 2.86 |
| 2024-06-30 | 2.61 |
| 2024-03-31 | 3.26 |
| 2023-12-31 | 2.62 |
| 2023-09-30 | 3.51 |
| 2023-06-30 | 3.43 |
| 2023-03-31 | 3.71 |
| 2022-12-31 | 3.32 |
| 2022-09-30 | 3.99 |
| 2022-06-30 | 3.51 |
| 2022-03-31 | 3.37 |
| 2021-12-31 | 2.98 |
| 2021-09-30 | 7.25 |
| 2021-06-30 | 5.82 |
| 2021-03-31 | 5.48 |
| 2020-12-31 | 4.60 |
| 2020-09-30 | 1.54 |
| 2020-06-30 | 2.13 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 1.39 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
